D.-W. Zhao et al. / Journal of Organometallic Chemistry 718 (2012) 89e95
93
(1C), 205.8 (1C), 220.9 (2C) (CO) ppm. IR: nCO ¼ 2014.6 (s), 1892.9
(vs), 1868.2 (vs), 1814.0 (vs) cmꢀ1. Anal. Calc. for C21H19FMo-
N4O4.0.25CH2Cl2: C, 48.38; H, 3.73; N, 10.62. Found: C, 48.80; H,
3.48; N, 11.00%.
1H, J ¼ 7.0 Hz), 7.11e7.23 (m, 2H), 7.49e7.52 (m, 1H) (C6H4), 7.78 (s,
1H, CH) ppm. 13C NMR (acetone-d6):
d 12.3, 17.4 (CH3), 69.7 (CH),
109.2 (C4 of pyrazole), 120.6, 129.6, 129.8, 132.1, 134.0, 136.9 (C6H4),
146.0, 156.8 (C3 and C5 of pyrazole), 201.3 (1C), 204.9 (1C), 212.6
(2C) (CO) ppm. IR: nCO ¼ 2002.1 (s), 1880.2 (vs), 1847.5 (vs), 1818.3
(vs) cmꢀ1. Anal. Calc. for C21H19BrN4O4W: C, 38.50; H, 2.92; N, 8.55.
Found: C, 38.57; H, 2.62; N, 8.67%.
3.5. Synthesis of (2-FC6H4)CH(3,5-Me2Pz)2W(CO)4 (5)
Compound 1 (0.27 g, 0.91 mmol) was added to a solution of
W(CO)5THF in THF, prepared in situ by the irradiation of a solution
of W(CO)6 (0.32, 0.91 mmol) in THF (40 ml) with a 300 W high-
pressure mercury lamp for 8 h, and the reaction mixture was stir-
red and heated at reflux for 10 h. Then the solvent was removed
under reduced pressure, and the residual solid was purified by
column chromatography on silica using CH2Cl2/hexane (2/1 v/v) as
eluent. The eluate was concentrated to dryness and the residual
solid was recrystallized from CH2Cl2/hexane to give yellowegreen
3.9. Synthesis of (2-C6H4)CH(3,5-Me2Pz)2Mo(CO)3Br (9)
This complex was obtained similarly using compound 3 instead
of compound 1 as described above for 4. Yield: 44%. 1H NMR
(DMSO-d6):
d
2.33, 2.65 (s, s, 6H, 6H, CH3), 6.22 (s, 2H, H4 of pyr-
azole), 7.07e7.21 (m, 2H), 7.33 (dd, J ¼ 7.1 Hz, J ¼ 1.3 Hz, 1H), 7.97
(dd, J ¼ 7.1 Hz, J ¼ 1.5 Hz, 1H) (C6H4), 7.58 (s, 1H, CH) ppm. 13C NMR
(DMSO-d6): d
10.7,15.4 (CH3), 70.4 (CH),107.7 (C4 of pyrazole),124.7,
solids of 5. Yield: 0.25 g (47%). 1H NMR (acetone-d6):
d
2.40, 2.51
128.7, 128.9, 136.7, 142.1, 161.4 (C6H4), 142.2, 152.5 (C3 and C5 of
pyrazole), 236.9 (CO) ppm. IR: nCO ¼ 2013.7 (vs), 1942.3 (vs), 1903.7
(vs) cmꢀ1. Anal. Calc. for C20H19BrMoN4O3: C, 44.55; H, 3.55; N,
10.39. Found: C, 44.65; H, 3.76; N, 10.28%.
(s, s, 6H, 6H, CH3), 6.35 (s, 2H, H4 of pyrazole), 6.21 (t, J ¼ 8.1 Hz),
7.11e7.19 (m, 2H), 7.40e7.45 (m, 1H) (C6H4), 8.07 (s, 1H, CH) ppm.
13C NMR: 11.8, 17.3 (CH3), 65.8 (CH), 108.2 (C4 of pyrazole), 117.5 (d,
d
JFC ¼ 21.8 Hz), 120.8 (d, JFC ¼ 10.9 Hz), 125.7, 127.9, 132.3 (d,
JFC ¼ 8.6 Hz), 158.4 (C6H4), 142.2, 156.1 (C3 and C5 of pyrazole), 200.5
(1C), 203.5 (1C), 212.0 (2C) (CO) ppm. IR: nCO ¼ 2003.0 (s), 1891.0
3.10. Synthesis of (2-C6H4)CH(3,5-Me2Pz)2W(CO)3Br (10)
(vs), 1850.7 (vs), 1821.0 (vs) cmꢀ1
.
Anal. Calc. for
Compound 3 (0.32 g, 0.91 mmol) was added to a solution of
W(CO)5THF in THF, prepared in situ by the irradiation of a solution
of W(CO)6 (0.32, 0.91 mmol) in THF (40 ml) with a 300 W high-
pressure mercury lamp for 8 h, and the reaction mixture was stir-
red and heated at reflux for 24 h. Then the solvent was removed
under reduced pressure, and the residual solid was purified by
column chromatography on silica using ethyl acetate/hexane (1/1
v/v) as eluent. The first yellowegreen band was characterized as
complex 8. Yield: 35 mg (5.9%). The second yellow band was
confirmed as complex 10. Yield: 0.15 g (27%). 1H NMR (DMSO-d6):
C21H19FN4O4W.0.25CH2Cl2: C, 41.47; H, 3.19; N, 9.10. Found: C,
41.24; H, 3.62; N, 9.60%.
3.6. Synthesis of (2-ClC6H4)CH(3,5-Me2Pz)2Mo(CO)4 (6)
This complex was obtained similarly using compound 2 instead
of compound 1 as described above for 4. Yield: 56%. 1H NMR:
d 2.47,
2.53 (s, s, 6H, 6H, CH3), 6.09 (s, 2H, H4 of pyrazole), 6.04e6.07 (m,
1H), 7.20e7.21 (m, 1H) (C6H4), 7.30e7.33 (m, 2H, C6H4 and CH),
7.37e7.41 (m, 1H, C6H4) ppm. 13C NMR:
d
12.1, 16.5 (CH3), 67.0 (CH),
d
2.35, 2.67 (s, s, 6H, 6H, CH3), 6.30 (s, 2H, H4 of pyrazole), 7.02 (t,
108.2 (C4 of pyrazole), 128.2, 128.9, 131.2, 131.3, 131.8, 132.4 (C6H4),
142.5, 155.8 (C3 and C5 of pyrazole), 202.5 (1C), 205.7 (1C), 221.0
(2C) (CO) ppm. IR: nCO ¼ 2009.8 (vs), 1888.3 (vs), 1855.5 (vs), 1818.9
(vs) cmꢀ1. Anal. Calc. for C21H19ClMoN4O4: C, 48.25; H, 3.66; N,
10.72. Found: C, 48.24; H, 3.39; N, 10.82%.
J ¼ 7.2 Hz, 1H), 7.12 (t, J ¼ 7.1 Hz, 1H), 7.33 (d, J ¼ 7.1 Hz, 1H), 7.95 (d,
J ¼ 7.2 Hz, 1H) (C6H4), 7.62 (s, 1H, CH) ppm. 13C NMR (DMSO-d6):
d
10.7, 16.0 (CH3), 71.0 (CH), 108.0 (C4 of pyrazole), 124.0, 128.1,
129.4, 135.5, 141.6, 157.0 (C6H4), 142.1, 152.4 (C3 and C5 of pyrazole),
233.1 (CO) ppm. IR: nCO ¼ 2008.2 (vs), 1926.5 (vs), 1896.3 (vs) cmꢀ1
.
Anal. Calc. for C20H19BrN4O3W: C, 38.30; H, 3.05; N, 8.93. Found: C,
38.45; H, 3.35; N, 8.83%.
3.7. Synthesis of (2-ClC6H4)CH(3,5-Me2Pz)2W(CO)4 (7)
This complex was obtained similarly using compound 2 instead
of compound 1 as described above for 5. The eluent was CH2Cl2/
3.11. Heating complex 8 in THF
hexane (1/1 v/v). Yield: 35%. 1H NMR (acetone-d6):
d
2.41, 2.53 (s, s,
The solution of complex 8 (0.10 g, 0.15 mmol) in THF (30 ml) was
stirred and heated at reflux for 24 h. The solvent was removed
under reduced pressure, the residual solid was purified by column
chromatography on silica using ethyl acetate/hexane (1/1 v/v) as
eluent to give complex 10 as a yellowegreen solid. Yield: 80 mg
(85%).
6H, 6H, CH3), 6.20 (s, 2H, H4 of pyrazole), 6.01 (d, 1H, J ¼ 7.8 Hz),
7.14e7.27 (m, 3H) (C6H4), 7.84 (s, 1H, CH) ppm. 13C NMR (acetone-
d6):
d
12.1, 17.4 (CH3), 69.1 (CH), 109.1 (C4 of pyrazole), 129.2, 129.8,
132.2, 132.5, 132.6, 133.3 (C6H4), 145.9, 156.8 (C3 and C5 of pyrazole),
201.5 (1C), 205.0 (1C), 212.8 (2C) (CO) ppm. IR: nCO ¼ 2002.4 (s),
1879.3 (vs), 1846.8 (vs), 1817.3 (vs) cmꢀ1
. Anal. Calc. for
C21H19ClN4O4W.0.25CH2Cl2: C, 40.39; H, 3.11; N, 8.87. Found: C,
40.57; H, 3.23; N, 9.13%.
3.12. Synthesis of (2-ImC6H4)CH(3,5-Me2Pz)2 (11) (Im ¼ imidazol-
1-yl)
3.8. Synthesis of (2-BrC6H4)CH(3,5-Me2Pz)2W(CO)4 (8)
The solution of compound 3 (0.72 g, 2.0 mmol) imidazole (0.16 g,
2.4 mmol), CuI (0.1 g, 0.52 mmol), anhydrous Cs2CO3 (1.64 g,
The solution of compound 3 (0.11 g, 0.31 mmol) and W(CO)6
(0.11 g, 0.31 mmol) in THF (30 ml) was irradiated with a 300 W
high-pressure mercury lamp for 8 h at room temperature. The
solvent was removed under reduced pressure, and the residue was
purified by column chromatography on silica using CH2Cl2/hexane
(2/1 v/v) as eluent. The greeneyellow eluate was concentrated to
dryness, the residue was recrystallized from CH2Cl2/hexane to give
greeneyellow solids of 8. Yield: 0.10 g (49%). 1H NMR (acetone-d6):
5.0 mmol) and L-proline (0.12 g,1.0 mmol) in DMF (5 ml) was stirred
and heated at 120 ꢁC for 24 h. After cooling to room temperature,
water (100 ml) was added to the above-mentioned solution. The
aqueous solution was extracted with ethyl acetate (3 ꢂ 100 ml). The
organic layers were combined and dried over anhydrous MgSO4.
The solvent was removed under reduced pressure, the residual oil
was purified by column chromatography on silica. First, an ethyl
acetate/hexane (1/1 v/v) mixture was used as eluent to remove the
starting materials, then an ethyl acetate/methanol (5/1 v/v)
d
2.42, 2.54 (s, s, 6H, 6H, CH3), 6.20 (s, 2H, H4 of pyrazole), 5.98 (d,